What is Convergent Engineering?
Convergent Engineering operates at the intersection of advanced signal processing and medical device innovation. With a legacy spanning over 15 years, the firm provides specialized engineering services and product development expertise that bridge the gap between complex machine intelligence and practical clinical application. Their flagship offering, the FDA-cleared VentAssist system, exemplifies their technical proficiency in optimizing ventilator settings, a capability brought to market through a high-profile partnership with Philips Healthcare. The company serves a broad spectrum of clients, ranging from agile startups to established multinational corporations, consistently delivering solutions that enhance biomedical performance and patient outcomes.
How much funding has Convergent Engineering raised?
Convergent Engineering has raised a total of $87K across 1 funding round:
Debt
$87K
Debt (2021): $87K with participation from PPP
Key Investors in Convergent Engineering
PPP
Public-Private Partnership
What's next for Convergent Engineering?
With the successful closure of this latest investment, Convergent Engineering is entering a critical phase of operational scaling. The firm is expected to prioritize the expansion of its R&D capabilities, focusing on the integration of next-generation signal processing algorithms into its existing product suite. Furthermore, the company will likely leverage this financial backing to strengthen its commercial partnerships and explore new therapeutic areas where machine intelligence can provide significant clinical utility. As the regulatory landscape for AI-driven medical devices evolves, Convergent Engineering remains well-positioned to maintain its competitive advantage through rigorous engineering standards and strategic market alignment.
See full Convergent Engineering company page
